Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

The Paracrine Function of Mesenchymal Stem Cells in Response to Pulsed Focused Ultrasound.

Razavi M., Rezaee M., Telichko A., Inan H., Dahl J., Demirci U.

Laboratory Study on Chronic Inflammation, Immune Modulation, published in Cell Transplant (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Cell Transplant (2020)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
33028105
PMCID
PMC7784560
DOI
10.1177/0963689720965478
Citations
6

Abstract (original English)

We studied the paracrine function of mesenchymal stem cells (MSCs) derived from various sources in response to pulsed focused ultrasound (pFUS). Human adipose tissue (AD), bone marrow (BM), and umbilical cord (UC) derived MSCs were exposed to pFUS at two intensities: 0.45 W/cm 2 I SATA (310 kPa PNP) and 1.3 W/cm 2 I SATA (540 kPa PNP). Following pFUS, the viability and proliferation of MSCs were assessed using a hemocytometer and confocal microscopy, and their secreted cytokine profile determined using a multiplex ELISA. Our findings showed that pFUS can stimulate the production of immunomodulatory, anti-inflammatory, and angiogenic cytokines from MSCs which was dependent on both the source of MSC being studied and the acoustic intensity employed. These important findings set the foundation for additional mechanistic and validation studies using this novel noninvasive and clinically translatable technology for modulating MSC biology.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Bone Marrow CellsEnzyme-Linked Immunosorbent AssayHumansMesenchymal Stem Cell TransplantationMesenchymal Stem CellsMicroscopy, Confocal

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research